Institutional HoldersBeta
Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.
Share classes (cover page of the 20-F filed 2026-03-05, as of 2025-12-31)
| Class | Listed | Shares outstanding | Held by 13F filers | % of class | Holders | CUSIP |
|---|---|---|---|---|---|---|
| Common stock | MDWD · NASDAQ | 12,835,148 | 5,818,298 | 45.3% | 78 | M68830112 |
Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.
Top holders (78 of 78 · M68830112)
change vs 2026-03-31Exited since 2026-03-31 (12 filers; largest 12 shown)
Large holders from 13D/13G (latest per reporting person, last 2 years)
Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.
| Reporting person | Form | Filed | Event | Shares | % of class |
|---|---|---|---|---|---|
| HOLD Alapkezelo Zrt. | SCHEDULE 13G/A | 2026-08-28 | 2026-08-27 | 1,348,323 | 10.4% |
| T. Rowe Price Associates, Inc. | SCHEDULE 13G/A | 2026-08-14 | 2026-06-30 | 641,075 | 5% |
| SALAMON STEVEN A J | SCHEDULE 13G/A | 2026-02-11 | 2025-12-31 | 912,319 | 7% |
| Aharon Gil | SCHEDULE 13G/A | 2026-02-11 | 2025-12-31 | 912,319 | 7% |
| Rosalind Master Fund L.P. | SCHEDULE 13G/A | 2026-02-11 | 2025-12-31 | 912,319 | 7% |
| Rosalind Advisors, Inc. | SCHEDULE 13G/A | 2026-02-11 | 2025-12-31 | 912,319 | 7% |
| Yelin Lapidot Holdings Management Ltd. | SCHEDULE 13G/A | 2026-02-05 | 2025-12-31 | 763,069 | 5.95% |
| Yair Lapidot | SCHEDULE 13G/A | 2026-02-05 | 2025-12-31 | 763,069 | 5.95% |
| Dov Yelin | SCHEDULE 13G/A | 2026-02-05 | 2025-12-31 | 763,069 | 5.95% |
| Len Blavatnik | SCHEDULE 13D/A | 2025-10-03 | 2025-09-30 | 1,481,521 | 11.56% |
| Access Industries Management, LLC | SCHEDULE 13D/A | 2025-10-03 | 2025-09-30 | 1,481,521 | 11.56% |
| Clal Life Sciences L.P. | SCHEDULE 13D/A | 2025-10-03 | 2025-09-30 | 1,172,710 | 9.15% |
| Access Industries Holdings LLC | SCHEDULE 13D/A | 2025-10-03 | 2025-09-30 | 1,481,521 | 11.56% |
| Access Industries, LLC | SCHEDULE 13D/A | 2025-10-03 | 2025-09-30 | 1,481,521 | 11.56% |
| Clal Industries Ltd. | SCHEDULE 13D/A | 2025-10-03 | 2025-09-30 | 1,481,521 | 11.56% |
| Clal Biotechnology Industries Ltd. | SCHEDULE 13D/A | 2025-10-03 | 2025-09-30 | 1,481,521 | 11.56% |
Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.